Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis

OBJECTIVE: This study evaluated the efficacy associated with switching to rifaximin in patients with hepatic cirrhosis receiving kanamycin sulfate for the treatment of hepatic encephalopathy and hyperammonemia. METHODS: We included 37 patients who switched from kanamycin sulfate to rifaximin at our...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Tatsumi, Ryoji, Suii, Hirokazu, Yamaguchi, Masakatsu, Arakawa, Tomohiro, Nakajima, Tomoaki, Kuwata, Yasuaki, Toyota, Joji, Hige, Shuhei
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8188012/
https://ncbi.nlm.nih.gov/pubmed/33361677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.6039-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars